A fresh look at pulmonary hypertension: practical takeaways for patient management

Dr John Coghlan going to share his insights with us on evidence - based treatment decisions in pulmonary arterial hypertension.

Facing anticoagulation dilemmas in venous thromboembolism

Professor Ingrid Pabinger held a presentation on extended anticoagulation in venous thromboembolism at the recent ESC Congress in Barcelona. We asked her to share the most important conclusions with us.

Influenza Vaccine Among Patients with Acute Coronary Syndromes: the VIP-ACS trial

Professor Remo Furtado had an important presentation on the Influenza Vaccine among patients with Acute Coronary Syndromes at this year’s ESC Congress. He is going to share his insights with us on the topic.

The importance of optimal RAASi therapy in heart failure

Professor Dan Atar had an important presentation on the importance of optimal RAASi therapy in heart failure at this year’s ESC Congress. He is going to share his insights with us on the topic.

Chronic coronary syndrome: re-thinking treatment management and outcome priorities

Professor Athanasios J. Manolis chaired a very eye-opening session on how to improve care in patients with chronic coronry syndrome at this years ESC Congress. We asked him to share his insights with us on the topic.

Dual antiplatelet therapy in practice

Professor Roxana Mehran chaired a very special Guidelines in Practice session at this year’s ESC Congress on dual antiplatelet therapy. We asked her to share the most important conclusions with us.

Guidelines in Practice: management of dyslipidaemias in the elderly

Professor Ricardo Asteggiano chaired a guideline is practice session on the management of dyslipidaemias in the elderly at this years ESC Congress. We asked him to share the most important conclusions with us.

2022 ESC-ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Professor Marion Delcroix co-chareid the session presenting the 2022 ESC-ERS guideline for the diagnosis and treatment of pulmonary hypertension at this year’s ESC congress. We asked her to highlighting the most important points of the new recommendations. The complete guideline can be found on the ESC website here.

Guidelines in Practice: dual antiplatelet therapy (DAPT)

Professor Robert Storey  co-chaired a very interesting Guidelines in Practice session on dual antiplatelet therapy at this year’s ESC Congress.  The session was started with a case presentation of a patient undergoing complex PCI for NSTE-ACS with high risk both for bleeding and trombotic complications. 

Cardiorenal benefits of finerenone: protecting the heart and kidneys

Professor George Bakris chaired a very interesting session at the recent ESC Congress on the Cardiorenal benefits of finerenone, which is indicated for the treatment of chronic kidney disease associated with type 2 diabetes. We asked him for sharing his insights ont he topic.

Getting to LDL-C goals and staying there long-term

Professor Mamas Mamas chaired a very interesting interactive session at this years ESC Congress in Barcelona. We asked him to share his insights with us on the topic.